European Journal of Molecular & Clinical Medicine

Abstract

Background: In December 2019 a new kind of Coronavirus called SARSCov-
2(Severe Acute Respiratory Syndrome Coronavirus-2) emerged in Wuhan,
China which causes mild to severe form of respiratory illness, which became a
global pandemic. While specific medications are not yet available, development
of different kinds of vaccine with promising results can be a key intervention
against the on-going pandemic caused by SARS-CoV-2.
Aims and Objectives:
1. To identify the determinants of acceptance of Covid 19 vaccine.
2. To identify the facilitators regarding Covid 19 vaccine.
Methods: A predesigned online questionnaire was prepared in the form of
Google forms and given to individuals at vaccination centre of KIMS Hubballi.
If the participant was illiterate questionnaire was explained and data was
collected by interviewer. The questionnaire comprised of general demographic
data, existing comorbidities and various factors determining the acceptance of
covid19 vaccine.